GlamorousAI
GlamAI proprietary platform, Rosalind, is the first AI platform to focus entirely on diseases where only a little information is available, a challenge that is currently intractable by other approaches. In weeks, Rosalind identified a hitherto undiscovered, nonetheless synthesizable hit candidate for the notoriously challenging and commercially attractive oncology target. Rosalind is not specific to any therapeutic area.
